12:00 AM
Sep 07, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ETEC vaccine: Began Phase III testing

Active Biotech AB (SSE:ACTI B), Lund, Sweden
Product: ETEC vaccine
Business: Infectious diseases
Therapeutic category: Immune modulation
Target: rCTB receptor in stomach lining...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >